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Despite improved early survival after an acute ST-seg-ment–elevation myocardial infarction (STEMI), the 
incidence of heart failure in the longer term has increased 
to 32% (1990–1999) from 10% only 20 years earlier 
(1,2). Standard risk assessment for treatment stratification 
in individual patients is based on the left ventricular (LV) 
ejection fraction (LVEF) (3–5) (eg, angiotensin-converting 
enzyme inhibitor therapy [5,6], implantable defibrillator 
devices [5,7]). However, this approach has some theoreti-
cal limitations because LVEF is only indirectly informa-
tive of myocardial contractility. Alternative approaches for 
estimating the clinical significance of an acute myocardial 
infarction (MI), such as imaging the size of infarction with 
cardiac MRI, also has theoretical limitations because the 
initial size of infarction is overestimated due to edema (8).
Until recently, there was a relative lack of evidence of 
the utility of cardiac MRI–derived myocardial strain for 
health outcomes in patients with STEMI (9). In studies of 
the Abciximab intravenous Versus intracoronary in ST- 
segment elevation Myocardial Infarction (or AIDA 
STEMI) population, Eitel et al (10) reported that fea-
ture tracking–derived global longitudinal strain but 
not circumferential strain was an independent risk fac-
tor after MI, even after adjusting for LVEF and infarct 
size. Registry data (11,12) support these findings. Ga-
vara et al (11) reported that feature tracking–derived 
circumferential strain is a univariable but not a mul-
tivariable prognostic indicator for major adverse car-
diac events (MACE) in a cohort of 323 patients dur-
ing 3-year follow-up after MI. Yoon et al (12) reported 
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Purpose: To investigate the prognostic value of circumferential left ventricular (LV) strain measured by using cardiac MRI for pre-
diction of major adverse cardiac events (MACE) following an acute ST-segment–elevation myocardial infarction (STEMI).
Materials and Methods: Participants with acute STEMI were prospectively enrolled from May 11, 2011, to November 22, 2012. 
Cardiac MRI was performed at 1.5 T during the index hospitalization. Displacement encoding with stimulated echoes (DENSE) 
and feature tracking of cine cardiac MRI was used to assess circumferential LV strain. MACE that occurred after discharge were 
independently assessed by cardiologists blinded to the baseline observations.
Results: A total of 259 participants (mean age, 58 years 6 11 [standard deviation]; 198 men [mean age, 58 years 6 11] and 61 wom-
en [mean age, 58 years 6 12]) underwent cardiac MRI 2.2 days 6 1.9 after STEMI. Average infarct size was 18% 6 13 of LV mass 
and circumferential strain was 213% 6 3 (DENSE method) and 224% 6 7 (feature- tracking method). Fifty-one percent (131 
of 259 participants) had presence of microvascular obstruction. During a median follow-up period of 4 years, 8% (21 of 259) expe-
rienced MACE. Area under the curve (AUC) for DENSE was different from that of feature tracking (AUC, 0.76 vs 0.62; P = .03). 
AUC for DENSE was similar to that of initial infarct size (P = .06) and extent of microvascular obstruction (P = .08). DENSE-
derived strain provided incremental prognostic benefit over infarct size for prediction of MACE (hazard ratio, 1.3; P , .01).
Conclusion: Circumferential strain has independent prognostic importance in study participants with acute ST-segment–elevation 
myocardial infarction.
Published under a CC BY 4.0 license.
Online supplemental material is available for this article.
This copy is for personal use only. To order printed copies, contact reprints@rsna.org
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similar findings using feature-tracking software from a dif-
ferent vendor.
Our aim was to investigate circumferential strain in relation-
ship to MACE in study participants with recent STEMI because, 
theoretically, loss of circumferential myofibers following MI may 
be particularly deleterious in participants with transmural infarc-
tion (13,14). Furthermore, circumferential strain is understud-
ied compared with longitudinal strain in participants after MI 
(15–17).
Displacement encoding with stimulated echoes (DENSE) (18) 
encodes myocardial displacement directly into the phase of the 
cardiac MRI signal allowing for extraction of myocardial strain 
with pixel-level resolution, conferring a high level of accuracy and 
reproducibility compared with other methods (18). We hypoth-
esized that DENSE-derived circumferential strain has superior 
prognostic value when compared with feature tracking of cine 
imaging.
Our specific hypotheses were to assess the comparative rela-
tionships for circumferential strain estimated by using feature-
tracking and DENSE methods, LVEF (a reference marker of LV 
systolic function) (19), initial infarct size (20), and infarct charac-
teristics (microvascular obstruction [21], myocardial salvage index 
[22]) against MACE.
Materials and Methods
Study Population
A prospective single-center cohort study was performed between 
May 11, 2011, and November 22, 2012. We enrolled all comers 
undergoing emergency invasive management for an acute STEMI 
at a regional cardiac center. Study participants with a contraindica-
tion to cardiac MRI were ineligible. The study had ethics approval 
(reference no. 10-S0703-28) and was publicly registered (clinical 
trial registration no. NCT 02072850). Written informed consent 
was secured from each participant.
Siemens Healthcare provided the DENSE work-in-progress 
cardiac MRI sequence and data analysis software as part of a 
research agreement with the University of Glasgow. The authors 
who are not employees of Siemens Healthcare had control of in-
clusion of any data and information that might present a conflict 
of interest for those authors who are employees of that industry.
Cardiac MRI Acquisition
Cardiac MRI was performed at 1.5 T (Magnetom Avanto; Sie-
mens Healthcare, Erlangen, Germany) by using an anterior 
phased-array body coil (12-element) and a posterior phased-array 
spine coil (24-element) 2 days after MI.
Cardiac MRI Protocol
The cardiac MRI protocol included cine cardiac MRI (balanced 
steady-state free precession), three short-axis two-dimensional 
echo-planar imaging DENSE (work-in-progress sequence 611, 
Siemens Healthcare) (23,24), T2-prepared balanced steady-state 
free precession sequence, and delayed-enhancement phase-sensi-
tive inversion-recovery pulse sequences (37).
The LV dimensions were assessed by using balanced steady-
state free precession cinematographic breath-hold sequences. The 
heart was imaged in multiple parallel short-axis planes of 7-mm 
thickness separated by 3-mm gaps. Typical imaging parameters 
were as follows: 3.3/1.2 (repetition time msec/echo time msec); 
field of view, 340 mm; flip angle, 80°; spatial resolution, 180 3 
256 mm; temporal resolution, 46 msec; bandwidth, 930 Hz/pixel.
T2 maps were acquired in short-axis sections covering the 
whole ventricle by using a T2-prepared balanced steady-state free 
precession sequence (work-in-progress sequence 488; Siemens 
Healthcare) (25). Typical imaging parameters were as follows: 
bandwidth, 947 Hz/pixel; flip angle, 70°; T2 preparations of 0 
msec, 24 msec, and 55 msec, respectively; matrix, 160 3 105 pix-
els; spatial resolution, 2.6 3 2.1 3 8.0 mm; and section thickness, 
8 mm.
Late gadolinium enhancement images covering the entire LV 
were acquired 10–15 minutes after intravenous injection of 0.15 
mmol/kg of gadoterate meglumine (Dotarem; Guebert, France) 
by using segmented phase-sensitive inversion-recovery turbo fast 
low-angle shot in a contiguous short-axis LV stack and three 
orthogonal long-axis planes. Microvascular obstruction was 
defined as a dark zone at early delayed enhancement imaging 
7 minutes after contrast material injection and within an area of 
late gadolinium enhancement. Typical imaging parameters were 
as follows: matrix, 192 3 256; flip angle, 25°; echo time, 3.36 
msec; bandwidth, 130 Hz/pixel; echo spacing, 8.7 msec; trigger 
pulse, 2. The voxel size was 1.8 3 1.3 3 8 mm3. Inversion times 
were individually adjusted to optimize nulling of visually normal 
myocardium (typical values, 200 to 300 msec).
Through-plane dephasing and two-point complementary spa-
tial modulation of magnetization were used for artifact suppres-
sion during DENSE acquisition (24). Three short-axis sections 
were acquired (basal, mid-LV, and apical). Fat suppression was 
carried out by using a fast water excitation option. Readout and 
phase-encoding direction of displacement were acquired in a single 
breath hold. Typical DENSE imaging parameters were as follows: 
32/8; flip angle, 20°; section thickness, 8 mm; field of view, 360 
mm 3 270 mm; matrix size, 112 3 84; displacement encoding 
of 0.2 p/mm; temporal resolution, 55 msec; echo-planar imaging 
Abbreviations
AUC = area under the curve, CI = confidence interval, DENSE = 
displacement encoding with stimulated echoes, LV = left ventricle, 
LVEF = LV ejection fraction, MACE = major adverse cardiac events, 
MI = myocardial infarction, STEMI = ST-segment–elevation MI
Summary
Peak circumferential strain provides prognostic value for major ad-
verse cardiac events over infarct size and characteristics revealed with 
contrast material–enhanced cardiac MRI.
Implications for Patient Care
 n A threshold for circumferential strain of greater than 211% 
identifies patients at increased risk of major adverse cardiovascular 
events.
 n Strain imaging with displacement encoding with stimulated 
echoes has emerging potential as a functional imaging marker 
for prognostication in patients with recent ST-segment–elevation 
myocardial infarction.
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Research team members (J.C., a physician) screened for ad-
verse events through national electronic medical records of the 
study participants and by contacting participants and their pri-
mary and secondary care physicians, as appropriate. Each event 
was reviewed by a cardiologist independent of the research team 
and blinded to all the clinical and cardiac MRI data (A.M., a car-
diologist). The adverse events were defined according to standard 
guidelines (29) and categorized as having occurred during the in-
dex admission or postdischarge.
Statistical Analysis
Statistical analysis was performed by using R (version 2.15 or 
higher; R Foundation for Statistical Computing, Vienna, Austria; 
https://www.r-project.org) under supervision of a biostatistician 
(C.H.). Normality was tested by using box plots. Continuous 
variables were expressed as means 6 standard deviations or medi-
ans and interquartile ranges (Q1, Q3), depending on distribution. 
Skewed distributions were analyzed by using Mann-Whitney or 
Kruskal-Wallis tests. A P value of , .05 was considered to indi-
cate statistical significance. Multivariable logistic regression mod-
els were constructed to assess the incremental prognostic utility of 
parameters over infarct size for MACE.
Receiver operating characteristic, Cox proportional hazards re-
gression, and Kaplan-Meier curves were used to identify potential 
predictors of MACE. The proportional hazards assumption was 
tested by using log-minus-log plots. Diagnostic cutoff values were 
identified from the “Optimal Cutpoints” package (30) by using 
the Youden index (31). Log-rank analysis was carried out to iden-
tify whether the cutoff value identified for these predictors was sta-
tistically significant. The difference in area under the curve (AUC) 
was compared by using the z statistic. The sample size calculation 
can be found in Appendix E1 (online).
Results
Characteristics of the Study Participants
A total of 300 of 343 screened participants referred for emergency 
percutaneous coronary intervention underwent 1.5-T cardiac 
MRI 2.2 days 6 1.9 (standard deviation) after hospital admission 
(Fig 1). Among the 300 study participants, 261 (87%) underwent 
DENSE imaging, whereas all participants (100%) underwent 
cine imaging. Thirty-nine (13%) participants did not undergo 
DENSE imaging, either because the method was unavailable (15 
of 300, 5%) or because of intolerance of the cardiac MRI exami-
nation (24 of 300, 8%) (Fig 1). The mean age for male partici-
pants (198 of 259, 76%) was 58 years 6 11 (range, 33–83 years) 
and that for female participants (61 of 259, 24%) was 58 years 
6 12 (range, 32–85 years). The characteristics of the participants 
with DENSE imaging findings are described in Table 1. The car-
diac MRI findings for participants are described in Table 2, and 
clinical examples are illustrated in Figure 2.
DENSE Image Quality
Image quality was high or adequate in the majority of DENSE 
and feature-tracking acquisitions for circumferential strain (Table 
E2 [online]). Fourteen of 783 (1.8%) DENSE myocardial seg-
factor of 8 and segmentation factor of 16; acquisition time of 20 
heart beats (Table E1 [online]).
Image Analysis
Image analysis was carried out by using dedicated cardiac MRI 
software (Argus and Syngo VE32D; Siemens Healthcare) by 
one author (D.C., a cardiologist with .3 years of MRI expe-
rience) and reviewed by another author (C.B., a cardiologist 
with .10 years of MRI experience). Image analysis was typi-
cally conducted within 2 weeks of acquisition. The extent of 
myocardial edema was defined as the amount of LV myocar-
dium with pixel values (T2, msec) greater than 2 standard de-
viations from remote myocardium and expressed as percent-
age of LV mass. Late gadolinium enhancement was quantified 
by using computer-assisted planimetry with the 5 standard 
deviation technique and expressed as percentage of LV mass. 
Microvascular obstruction was defined as a dark zone within areas 
of late gadolinium enhancement obtained 10–15 minutes after in-
travenous administration and expressed as percentage of LV mass 
(26).
DENSE was analyzed by using CIM_DENSE2D software 
(University of Auckland, New Zealand) (27). Circumferential 
strain was determined on basal, mid-LV, and apical DENSE im-
ages; all levels were averaged to determine global circumferential 
strain. Cardiac MRI feature-tracking software (Diogenes; TomTec 
Imaging Systems, Munich, Germany) was used to quantify strain 
from basal, mid-LV, and apical short-axis cine imaging spatially 
coregistered to the DENSE images. The same operator (K.M.) de-
rived strain following a standard protocol taught by the software 
manufacturer (28). All levels were averaged to determine global 
circumferential strain. We did not assess wall motion scores be-
cause these are no longer cited in clinical guidelines (5).
Myocardial salvage was calculated by subtraction of percent 
infarct size from percent area at risk. The myocardial salvage in-
dex was calculated by dividing the myocardial salvage area by the 
initial area at risk.
All data were analyzed from data sets in a random order. The 
image analysts were blinded to participant demographics and 
clinical outcomes. DENSE and cine image quality and artifact 
scoring were carried out by two operators in consensus (K.M., 
a cardiologist with .3 years of cardiac MRI experience; C.M., a 
MRI scientist with .10 years of cardiac MRI experience), and 
a third expert observer (X.Z., a MRI scientist with .10 years of 
cardiac MRI experience) acted as a blinded independent adjudi-
cator. A Likert scoring system was used to report image quality. 
Imaging data sets for DENSE and feature tracking (n = 20) were 
reanalyzed 2 weeks later in random order for intraobserver (K.M.) 
and interobserver (C.M.) variability.
Health Outcomes
Adverse health outcomes that are pathophysiologically 
linked with STEMI were prespecified (29). The primary 
composite outcome was spontaneous MACE defined as 
cardiac death, nonfatal myocardial infarction, or hospital-
ization for heart failure. Only serious adverse events aris-
ing after the index hospitalization (ie, after discharge) were 
evaluated.
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greater than or equal to 7.8% for microvascular obstruction (per-
centage of LV mass). By using Kaplan-Meier survival analysis and 
log-rank testing, the variables with discriminative potential were 
as follows: DENSE (x2 =19; P , .001), microvascular obstruction 
(x2 = 13; P , .001), infarct size (x2 = 9.4; P = .002), and feature 
tracking (x2 = 5.2; P = .02) (Table 3, Figures 3–6).
Incremental Prognostic Utility of Strain over Infarct Size 
for Health Outcomes
A multivariable Cox proportional hazards regression model was 
used to assess whether baseline parameters provided incremental 
prognostic benefit over initial infarct size for MACE.
Circumferential strain with DENSE was associated with in-
cremental prognostic value over baseline infarct size for predic-
tion of MACE (hazard ratio, 1.26; 95% confidence interval 
[CI]: 1.09, 1.46; P = .002) (Table 4), whereas LVEF (hazard ra-
tio, 0.98; 95% CI: 0.92, 1.04; P = .44), microvascular obstruc-
tion (hazard ratio, 1.02; 95% CI: 0.94, 1.11; P = .61), myo-
cardial salvage index (hazard ratio, 0.99; 95% CI: 0.96, 1.01; 
P = .11), and circumferential strain with feature tracking (hazard 
ratio, 1.03; 95% CI: 0.94, 1.12; P = .54) had no incremental 
prognostic value.
Discussion
We investigated the comparative prognostic utility of circumfer-
ential strain revealed with cardiac MRI in a reasonably large and 
unselected population of participants with STEMI per complete 
follow-up during a 4-year period. Our main findings are as fol-
lows: First, feature tracking was feasible in all the participants. 
DENSE was feasible and informative in the majority of partici-
pants. Second, circumferential strain with DENSE has incremen-
tal prognostic value over initial infarct size for the future occur-
rence of MACE during a median of 4-year follow-up after the 
index hospitalization. Finally, a circumferential strain threshold of 
211% with DENSE has higher predictive value than does initial 
infarct size threshold of 32% of LV mass to identify participants at 
higher risk of MACE. Strain imaging with DENSE has emerging 
potential as reference functional biomarker for prognostication in 
patients after an acute STEMI.
Circumferential Strain
Strain imaging is increasingly adopted for clinical and 
research purposes in patients following MI, represent-
ing an advance on historical approaches, such as wall 
motion scoring (5). Our results indicate that loss of cir-
cumferential strain with DENSE has clinically signifi-
cant implications in patients following MI, while obviat-
ing contrast. DENSE resolves circumferential strain with 
high precision and accuracy (23,24). LV pump function 
(or pump failure) is a critical determinant of heart fail-
ure after MI. Longitudinal myofibers are distributed 
within the subendocardium of the heart. Given the endo- 
epicardial wave-front of ischemia (32), these fibers are ana-
tomically predisposed to infarction. Circumferential myo-
fibers are located within the midwall and epicardium and 
are therefore less susceptible to ischemia and subsequent in-
ments were nondiagnostic. Two participants underwent nondiag-
nostic DENSE imaging. All of the cine images were diagnostic. 
The intraclass correlation coefficient was excellent (.0.90) for all 
intraobserver and interobserver analyses. The mean bias between 
attempts or operators was not clinically significant at 1% (Table 
E3 [online]).
Prognostic Value of Cardiac MRI Parameters
The median follow-up duration was 4 years (median, 1501 days; 
range, 1241–1802 days). Follow-up was achieved in all (259 of 
259, 100%) study participants. Among 259 participants, 21 par-
ticipants (8%) experienced spontaneous MACE after discharge 
from their index admission. The associations of global circum-
ferential strain, LVEF, initial infarct size, and myocardial salvage 
index in relationship to MACE were assessed by using receiver 
operating characteristic analysis. The optimal cutoffs for MACE 
for all the baseline variables were identified by using the Youden 
index (31) (Table 3).
The AUC of circumferential strain with DENSE to predict 
MACE was 0.76. Initial infarct size (AUC, 0.67), microvascular 
obstruction extent (AUC, 0.63), and feature tracking (AUC, 0.62) 
had similar AUC values to predict MACE. AUC for DENSE was 
different from that of feature tracking (z statistic, 2.2; P = .03), 
whereas it was not different from initial infarct size (z statistic, 1.8; 
P = .06) or extent of microvascular obstruction (z statistic, 1.7; P 
= .08). LVEF (AUC, 0.35; P = .03) and myocardial salvage index 
(AUC, 0.34; P = .02) were classified as “below chance” to predict 
MACE.
The optimal discriminative cutoffs for MACE were greater 
than or equal to 211% for circumferential strain with DENSE, 
greater than or equal to 219% for feature tracking, greater than or 
equal to 32% for initial infarct size (percentage of LV mass), and 
Figure 1: Consolidated Standards of Reporting Trials, or  
CONSORT, study diagram. CMR = cardiac MRI, DENSE = 
displacement encoding with stimulated echoes, STEMI = ST-
segment–elevation myocardial infarction.
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Table 1: Demographics of Participants with Acute STEMI
Characteristic All Participants (n = 259) No MACE (n = 238) MACE (n = 21) P Value
Age (y)* 58 6 11 58 6 11 54 6 7 .08
Sex .57
 Male 198 (76) 183 15
 Female 61 (24) 55 6
Weight (kg)* 82 6 15 82 6 15 81 6 14 .73
Body mass index (kg/m2)* 29 6 5 29 6 5 29 6 5 .41
Hypertension 78 (30) 71 7 .73
Current smoker 159 (61) 142 16 .14
Hypercholesterolemia 70 (27) 7 62 .45
Diabetes mellitus† 27 (10) 4 23 .18
Presenting characteristics*
 Heart rate (bpm) 77 6 17 77 6 17 83 6 15 .10
 Systolic blood pressure (mm Hg) 136 6 25 135 6 24 148 6 29 .03
 Time from symptom onset to reperfusion (min) 251 6 200 247 6 191 287 6 281 .39
No. of diseased arteries‡
 One 147 (57) 136 10 …
 Two 78 (30) 69 8 .63
 Three 34 (13) 28 3 …
Anterior infarction 97 (37) 12 85 .14
TIMI coronary flow grade before PCI
 0/1 193 (75) 174 20 …
 2 44 (17) 44 0 .14
 3 22 (8) 20 1 …
TIMI coronary flow grade after PCI
 0/1 4 (2) 4 0 …
 2 8 (3) 8 1 .46
 3 247 (95) 226 20 …
Note.—Unless otherwise specified, data are the number of participants, with percentages in parentheses. MACE = major adverse cardiac 
events, PCI = percutaneous coronary intervention, STEMI = ST-segment–elevation myocardial infarction, TIMI = thrombolysis in myocar-
dial infarction.
* Data are means 6 standard deviations.
† Diabetes mellitus was defined as a history of diet-controlled or treated diabetes.
‡ Multivessel coronary artery disease was defined according to the number of stenoses of at least 50% of the reference vessel diameter by 
using visual assessment.
Table 2: Cardiac MRI Characteristics for the Study Population
Parameter All Participants (n = 259) No MACE (n = 238) MACE (n = 21) P Value
LV ejection fraction (%)* 56 6 10 55 6 9 50 6 12 .02
LVEDVi (mL/m2) 79 (26, 44) 79 (69, 86) 90 (74, 101) .02
LVESVi (mL/m2) 35 (26, 44) 35 (25, 43) 44 (32, 54) .01
Circumferential strain*
 DENSE (%) 213 6 3 214 6 3 211 6 3 ,.01
 Feature tracking (%) 224 6 7 224 6 6 221 6 8 .04
Myocardial salvage index (%) 60 (43, 84) 61 (44, 86) 43 (31, 64) .02
Infarct size† 16 (7, 27) 15 (6,26) 22 (14, 39) .01
Microvascular obstruction† 0 (0, 3) 0 (0, 3) 1 (0, 11) .04
Note.—Unless otherwise specified, data are medians with interquartile ranges in parentheses. DENSE = displacement encoding with 
stimulated echoes, LV = left ventricle, LVEDVi = LV end-diastolic volume indexed to body surface area, LVESVi = LV end-systolic volume 
indexed to body surface area, MACE = major adverse cardiac events.
* Data are means 6 standard deviations.
† Assessed as the percentage of LV mass.
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Our findings are consistent with those of two studies (11,12) 
that reported feature tracking–derived circumferential strain as 
a univariable but not a multivariable predictor of MACE. As in 
our own study, both had comparatively long follow-up dura-
tions (median of 3.0 years [11] and 7.8 years [12], respectively). 
farction based on anatomic location. Circumferential strain 
may therefore represent a functional biomarker of myo-
cardial salvage and the propensity to recovery of LV pump 
function in the longer term. Loss of circumferential strain 
early after MI would then become more important (33).
Figure 2: Images demonstrate strain and adverse health outcomes in a 61-year-old man who presented with acute anterior 
ST-segment–elevation myocardial infarction (STEMI). Coronary angiography revealed occluded left anterior descending artery. 
Cardiac MRI at day 2 after STEMI revealed anteroseptal wall motion abnormality. A, Cine image at midventricular level in, B, 
end-diastole during midsystole. C, Late gadolinium enhancement imaging at same midventricular level shows left ventricle (LV) 
ejection fraction of 45%, infarct size (white arrows) of 43% of LV mass, and extent of microvascular obstruction (black arrow) 
of 12% of LV mass. D, T2 mapping was used to calculate myocardial salvage index of 31%; arrows indicate edema. E, Graph 
shows peak global circumferential strain with displacement encoding with stimulated echoes of 29% (arrow). This patient pre-
sented acutely to hospital with heart failure at 6 months after discharge.
Table 3: Cutoffs for Prediction of MACE in 259 Patients
Parameter AUC*
Cutoff  
Value† Z Statistic P Value‡ Sensitivity (%)§ Specificity (%)§
Kaplan-Meier  
Survival  
Analyses (x2)
Log-Rank 
P Value
LV ejection fraction (%) 0.36 (0.23, 0.49) 71 NA … 10 (2/21) 96 (228/238) 0.02 .89
Myocardial salvage index (%) 0.34 (0.22, 0.46) 28 NA … 94 (19/21) 11 (26/238) 0.01 .97
Infarct size|| 0.67 (0.54, 0.81) 32 1.8 .06 43 (9/21) 89 (211/238) 9.4 ,.01
Microvascular obstruction|| 0.63 (0.48, 0.78) 7.8 1.7 .08 43 (9/21) 89 (212/238) 13 ,.01
Global circumferential  
  strain (%)
 DENSE 0.76 (0.64, 0.87) 211 Reference … 67 (14/21) 79 (188/238) 19 ,.01
 Feature tracking 0.62 (0.47, 0.76) 219 2.2 .03 47 (9/21) 79 (188/238) 5.2 .02
Note.— There were 21 patients with major adverse cardiac events (MACE) and 238 patients with no MACE. AUC = area under the curve, 
DENSE = displacement encoding with stimulated echoes, LV = left ventricle, NA = not applicable.
* Data in parentheses are 95% confidence intervals.
† Cutoffs were derived from the same data set, not from a validation data set, and may overestimate performance.
‡ Compared with DENSE.
§ Data in parentheses are numerators and denominators.
|| Assessed as the percentage of LV mass.
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dimensions and microvascular obstruction that change dynami-
cally within the first 48 hours after MI (35). The other two studies 
are retrospective in nature; selected from cardiac MRI registries in 
which patients after STEMI were referred for a cardiac MRI, pos-
sibly resulting in selection bias. In the study by Yoon et al (12), the 
time range for cardiac MRI was 1–30 days after MI. In the study 
In a landmark study investigating the prognostic value of feature 
tracking–derived strain pooled from clinical trials, Eitel et al (10) 
identified feature-tracking longitudinal and circumferential strain 
as univariable predictors of MACE. The timing of cardiac MRI 
in these studies ranged from 1–10 days after MI (34). This time 
interval is comparatively long, which is especially relevant for LV 
Figure 3: Graphs show Kaplan-Meier survival curves for 259 par-
ticipants with ST-segment–elevation myocardial infarction grouped by 
displacement encoding with stimulated echoes (DENSE)–derived strain 
and major adverse cardiac events (n = 21) after discharge from hospi-
tal during follow-up over 4 years.
Figure 4: Graphs show Kaplan-Meier survival curves for 259 par-
ticipants with ST-segment-–elevation myocardial infarction grouped by 
feature tracking–derived strain and major adverse cardiac events (n = 
21) after discharge from hospital to 4-year follow-up.
Figure 5: Graphs show Kaplan-Meier survival curves for 259 par-
ticipants with ST-segment-–elevation myocardial infarction grouped 
by initial infarct size and major adverse cardiac events (n = 21) after 
discharge from hospital to 4-year follow-up.
Figure 6: Graphs show Kaplan-Meier survival curves for 259 par-
ticipants with ST-segment-–elevation myocardial infarction grouped by 
extent of late microvascular obstruction and major adverse cardiac 
events (n = 21) after discharge from hospital to 4-year follow-up. LV = 
left ventricle.
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diac MRI or technetium 99m sestamibi sin-
gle-photon emission CT found that infarct 
size measured within 1 month of the initial 
presentation was strongly associated with 
all-cause mortality and hospitalization for 
heart failure within 1 year (20). Our results 
extend the evidence on the prognostic im-
portance of infarct size in the longer term (4 
years) and lend further support to the value 
of infarct size as a more informative surro-
gate for therapeutic efficacy than LVEF. We 
found that an infarct size of greater than 
or equal to 32% of LV mass represents a 
threshold for MACE in the longer term.
Unlike the meta-analysis of 1025 pa-
tients presented by van Kranenberg et al 
(21), microvascular obstruction did not pro-
vide incremental prognostic benefit over in-
farct size in our study. This is most likely due 
to the number of events in our study (n = 
21; 8%) compared with the meta-analysis (n 
= 130; 13%). There are a number of poten-
tial explanations. Our number of events is 
numerically smaller. Microvascular obstruc-
tion only occurs in a subset of patients (ie, 
half of patients are affected). Furthermore, 
the extent of microvascular obstruction and 
infarct size are highly correlated (21).
Our study had some limitations. We 
do not have information on longitudinal 
strain by using cardiac MRI or echocar-
diography. We performed a single-center 
study and further research is warranted. 
The number of MACE was low (21 of 
259, 8%), which restricts variable use in 
multivariable regression analysis. We did 
not use an independent validation set of participants with 
STEMI, and thus these cutoffs would overestimate perfor-
mance. We used a work-in-progress echo-planar imaging 
DENSE method. Spiral cine MRI with DENSE is now avail-
able. Because this method may have enhanced diagnostic per-
formance, further studies seem warranted.
In conclusion, peak circumferential strain with displacement 
encoding with stimulated echoes MRI provides incremental 
prognostic value over infarct size and pathologies revealed with 
contrast-enhanced cardiac MRI for major adverse cardiac events.
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by Gavara et al (11), cardiac MRI was performed on average 7 
days after STEMI. In this study, global circumferential strain was 
a univariable but not a multivariable predictor of MACE.
Considering the overall number of MACE, the number of in-
hospital MACE (34 of 259, 14%) was comparably high. Because 
only those MACE that occur after the initial cardiac MRI should 
be counted for risk prediction, we restricted the health outcomes 
analysis to include only events that occurred after discharge. We 
adopted this stringent approach to rule out the possibility of 
overlap between MACE that may be closely associated with the 
timing of cardiac MRI in-hospital. Furthermore, MACE in this 
analysis were spontaneous and, in line with regulatory guidelines 
(29), did not include revascularizations. The rate of MACE after 
discharge (8%) reflects the fact that in-hospital MACE and re-
vascularizations were not included, as has been the case in other 
imaging cohort studies (22,36).
Infarct Size, Microvascular Obstruction
We also studied the comparative prognostic value of infarct size 
versus LVEF after MI. A patient-level analysis of 2632 participants 
with infarct size assessed by using contrast material–enhanced car-
Table 4: Incremental Prognostic Benefit of Circumferential Strain over Baseline 
Infarct Size for Composite Health Outcomes
Analysis Hazard Ratio* P Value
Univariable analysis
 Initial infarct size† 1.04 (1.01, 1.07) .01
 Global circumferential strain (%)
  DENSE 1.26 (1.12, 1.48) ,.01
  Feature tracking 1.07 (1.00, 1.15) .04
 LV ejection fraction at baseline (%) 0.95 (0.91, 0.99) .02
 Myocardial salvage index 0.98 (0.96, 1.00) .02
 Microvascular obstruction† 1.07 (1.02, 1.14) .01
Multivariable analysis
 Model 1, infarct size + DENSE
  Initial infarct size† 1.01 (0.98, 1.04) .44
  DENSE, ECC (%) 1.26 (1.09, 1.46) .002
 Model 2, infarct size + feature tracking
  Initial infarct size† 1.03 (1.00, 1.07) .10
  Feature tracking, ECC (%) 1.03 (0.94, 1.12) .54
 Model 3, infarct size + LV ejection fraction
  Initial infarct size† 1.03 (0.99, 1.07) .15
  LV ejection fraction at baseline (%) 0.98 (0.92, 1.04) .44
 Model 4, infarct size + myocardial salvage index
  Initial infarct size† 1.03 (0.99, 1.08) .11
  Myocardial salvage index 0.99 (0.96, 1.01) .11
 Model 5, infarct size + microvascular obstruction
  Initial infarct size† 1.03 (0.99, 1.08) .13
  Microvascular obstruction† 1.02 (0.94, 1.11) .61
Note.—DENSE = displacement encoding with stimulated echoes, ECC = global circumfer-
ential strain, LV = left ventricle, MACE = major adverse cardiac events.
* Data in parentheses are 95% confidence intervals.
† Assessed as the percentage of LV mass.
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